Extract from the Register of European Patents

EP Citations: EP3570864

Cited inSearch
Type:Patent literature
Publication No.:WO2016011208  [I]
 (PROTAGONIST THERAPEUTICS INC [US], et al) [I] 1-15 * page 177 - page 219; tables 3-8 * * sequences 1-1029 * * page 196; sequence 645 *;
Type:Patent literature
Publication No.:WO2017011820  [AP]
 (PROTAGONIST THERAPEUTICS INC [US], et al) [AP] 1-15 * sequences 1-1256 * * tables E3A-E34 ** page 196; sequence 645 *;
Type:Non-patent literature
Publication information:[A]  - CHRISTIANE QUINIOU ET AL, "Specific targeting of the IL-23 receptor, using a novel small peptide noncompetitive antagonist, decreases the inflammatory response", AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY , INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, US, (20141115), vol. 307, no. 10, doi:10.1152/ajpregu.00540.2013, ISSN 0363-6119, pages R1216 - R1230, XP055721662 [A] 1-15 * page 1217; figure 1 * * page 1219, column r, paragraph 5 - page 1220, column l, paragraph 1 *
DOI: http://dx.doi.org/10.1152/ajpregu.00540.2013
Type:Non-patent literature
Publication information:[A]  - MILAN KUCHAR ET AL, "Human interleukin-23 receptor antagonists derived from an albumin-binding domain scaffold inhibit IL-23-dependent ex vivo expansion of IL-17-producing T-cells", PROTEINS: STRUCTURE, FUNCTION, AND BIOINFORMATICS, (20131101), doi:10.1002/prot.24472, ISSN 0887-3585, pages n/a - n/a, XP055109904 [A] 1-15 * abstract * * page 2; figure 1 * * page 9; table 1 *
DOI: http://dx.doi.org/10.1002/prot.24472
Cited inInternational search
Type:Patent literature
Publication No.:US2003166138  [A]
 (KINSELLA TODD [US], et al) [A] 1-2, 9/1-2, 10/9/1-2, 12-13 14/12-13 * ; claim 1 *;
Type:Patent literature
Publication No.:WO2016011208  [A]
 (PROTAGONIST THERAPEUTICS INC [US], et al) [A] 1-2, 9/1-2, 10/9/1-2, 12-13 14/12-13 * ; paragraphs [0010], [0011], [0013] *;
Type:Patent literature
Publication No.:US2016039878  [A]
 (GALLAGHER GRANT [US], et al) [A] 1-2, 9/1-2, 10/9/1-2, 12-13 14/12-13 * ; abstract *;
Type:Patent literature
Publication No.:WO2017011820  [PY]
 (PROTAGONIST THERAPEUTICS INC [US], et al) [PY] 1-2, 9/1-2, 10/9/1-2, 12-13 14/12-13* ; entire document *